<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04802993</url>
  </required_header>
  <id_info>
    <org_study_id>2017/151-31</org_study_id>
    <nct_id>NCT04802993</nct_id>
  </id_info>
  <brief_title>Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate</brief_title>
  <official_title>Survival Among Elderly Patients in Sweden With Right-sided Pancreatic Adenocarcinoma Depending on Resection Rate of Pancreaticoduodenectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Linkoeping University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this population-based study is to investigate how a high resection rate of&#xD;
      pancreaticoduodenectomy affects overall survival among patients aged ≥70 years with&#xD;
      pancreatic ductal adenocarcinoma. The secondary aim is to determine if a high resection rate&#xD;
      of pancreaticoduodenectomy increases perioperative morbidity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Actual">October 2, 2020</completion_date>
  <primary_completion_date type="Actual">October 2, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>A little more than 10 years (from first patient to vital status)</time_frame>
    <description>Overall survival among patients aged 70 years and over with pancreatic ductal adenocarcinoma in the pancreatic head</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severe complications after pancreaticoduodenectomy</measure>
    <time_frame>Around 10 years (patients diagnosed between 1 January 2010 and 31 December 2018, latest dismissal from hospital january 2020)</time_frame>
    <description>The rate of severe complications among patients aged 70 years and over who had undergone pancreaticoduodenectomy for any reason</description>
  </secondary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Actual">5123</enrollment>
  <condition>Pancreatic Ductal Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>All patients with pancreatic ductal adenocarcinoma aged 70 years and older</arm_group_label>
    <description>All patients in the registry aged 70 years and older with right-sided pancreatic ductal adenocarcinoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>All patients with pancreatic ductal adenocarcinoma aged 70-79 years</arm_group_label>
    <description>All patients in the registry aged 70-79 years with right-sided pancreatic ductal adenocarcinoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>All patients with pancreatic ductal adenocarcinoma aged 80 years and older</arm_group_label>
    <description>All patients in the registry aged 80 years and older with right-sided pancreatic ductal adenocarcinoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>All patients resected with pancreaticoduodenectomy, all ages</arm_group_label>
    <description>All patients in the registry resected with pancreaticoduodenectomy during the study period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>All patients resected with pancreaticoduodenectomy, aged 70-79 years</arm_group_label>
    <description>All patients in the registry resected with pancreaticoduodenectomy during the study period, aged 70-79 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>All patients resected with pancreaticoduodenectomy, aged 80 years and older</arm_group_label>
    <description>All patients in the registry resected with pancreaticoduodenectomy during the study period, aged 80 years and older</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resection rates</intervention_name>
    <description>All groups are divided into one high- and one low resection rate group depending on percentage of patients with pancreatic ductal adenocarcinoma resected per county and year (first three groups) and resection rate of pancreaticoduodenectomy per 100 000 inhabitants per county (last three groups)</description>
    <arm_group_label>All patients resected with pancreaticoduodenectomy, aged 70-79 years</arm_group_label>
    <arm_group_label>All patients resected with pancreaticoduodenectomy, aged 80 years and older</arm_group_label>
    <arm_group_label>All patients resected with pancreaticoduodenectomy, all ages</arm_group_label>
    <arm_group_label>All patients with pancreatic ductal adenocarcinoma aged 70 years and older</arm_group_label>
    <arm_group_label>All patients with pancreatic ductal adenocarcinoma aged 70-79 years</arm_group_label>
    <arm_group_label>All patients with pancreatic ductal adenocarcinoma aged 80 years and older</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients registered in the Swedish National Registry for tumours in the pancreatic and&#xD;
        periampullary region diagnosed with right-sided pancreatic adenocarcinoma or resected with&#xD;
        pancreaticoduodenectomy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed between 1 January 2010 and 31 December 2018&#xD;
&#xD;
          -  Registered in the Swedish National Registry for tumours in the pancreatic and&#xD;
             periampullary region&#xD;
&#xD;
          -  Either a diagnosis of pancreatic ductal adenocarcinoma of the pancreatic head or&#xD;
             having been resected with pancreaticoduodenectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 15, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Linkoeping University</investigator_affiliation>
    <investigator_full_name>Bergthor Björnsson</investigator_full_name>
    <investigator_title>Ass. Professor, senior consultant</investigator_title>
  </responsible_party>
  <keyword>pancreaticoduodenectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data cannot be further shared by the researchers but is available on application to the Swedish National Registry for tumours in the pancreatic and periampullary region, provided the application is approved by the Swedish Ethical Review Authority</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

